Sherryl Copeland
Family · Hazlehurst, GANPI 1497976781
Payments from drug & device makers
Across 44 payments — averaging $18.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi-aventis U.S. LLC$153
- Corcept Therapeutics$97
- Novo Nordisk$71
- Vanda Pharmaceuticals Inc.$56
- Aimmune Therapeutics, Inc.$47
- Lilly USA, LLC$46
- plus $355 from 16 others
What the payments were for
- Food & beverage$825100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi-aventis U.S. LLC | 8 | $153 |
| Corcept Therapeutics | 5 | $97 |
| Novo Nordisk | 4 | $71 |
| Vanda Pharmaceuticals Inc. | 2 | $56 |
| Aimmune Therapeutics, Inc. | 2 | $47 |
| Lilly USA, LLC | 2 | $46 |
| Pfizer | 3 | $42 |
| AstraZeneca | 2 | $39 |
| Phathom Pharmaceuticals, Inc. | 1 | $31 |
| Exact Sciences | 2 | $29 |
| AbbVie | 2 | $27 |
| Eisai Inc. | 1 | $21 |
| Amgen | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Biohaven Pharmaceuticals, Inc. | 1 | $19 |
| GSK | 1 | $19 |
| Merck | 1 | $18 |
| Johnson & Johnson | 1 | $17 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Antares Pharma, Inc. | 1 | $13 |
How this compares
$825 in reported general payments places this provider in the 60th percentile of 6,258 family providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 210 | $228,405 |
| OzempicSemaglutide | 122 | $131,312 |
| JardianceEmpagliflozin | 103 | $92,138 |
| EliquisApixaban | 90 | $77,440 |
| JanuviaSitagliptin Phosphate | 78 | $67,732 |
| XareltoRivaroxaban | 67 | $51,467 |
| LinzessLinaclotide | 71 | $48,260 |
| MyrbetriqMirabegron | 47 | $26,180 |
| Tresiba Flextouch U-200Insulin Degludec | 33 | $25,446 |
| RybelsusSemaglutide | 19 | $23,492 |
| FarxigaDapagliflozin Propanediol | 30 | $19,419 |
| Tresiba Flextouch U-100Insulin Degludec | 22 | $18,864 |
| TrulicityDulaglutide | 11 | $17,096 |
| VraylarCariprazine Hcl | 11 | $15,339 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 32 | $13,184 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $46 | $245,501221 claims |
| Novo NordiskOzempic, Rybelsus | $71 | $154,803141 claims |
| PfizerEliquis, Premarin | $42 | $79,731101 claims |
| MerckJanuvia | $18 | $67,73278 claims |
| AbbVieLinzess, Vraylar | $27 | $63,59982 claims |
| Johnson & JohnsonXarelto | $17 | $51,46767 claims |
| AstraZenecaFarxiga, Symbicort, Breztri Aerosphere | $39 | $38,20874 claims |
| GSKIncruse Ellipta | $19 | $4,23611 claims |
| Sanofi-aventis U.S. LLCLantus | $153 | $2,92215 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 6,258 family providers in Georgia.
Other family in Hazlehurst
- Allie McAllisterMarietta$299K
- Tonita WashingtonLawrenceville$153K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
- Jessica FeehanCanton$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.